IMM Ann: Approval to start Efti & Bavencio trial in urothelial cancer - 1st May 2023, 8:12am

annb0t

annb0t

Top 20
IMM Ann: Approval to start Efti & Bavencio trial in urothelial cancer
Price Sensitive: Y
Date: 1st May 2023, 8:12am

>>> Read announcement: Google: IMM Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
IMM Ann: Immutep Quarterly Activities Report and Appendix 4C - 31st Oct 2023, 8:43am
Replies
0
Views
86
annb0t
annb0t
annb0t
IMM Ann: Annual Report filed on Form 20-F with SEC - 25th Oct 2023, 11:01am
Replies
0
Views
86
annb0t
annb0t
annb0t
IMM Ann: Immutep receives Australian R&D Tax Incentive - 25th Oct 2023, 10:53am
Replies
0
Views
84
annb0t
annb0t
annb0t
IMM Ann: Results of Meeting - 24th Oct 2023, 11:52am
Replies
0
Views
70
annb0t
annb0t
annb0t
IMM Ann: Immutep AGM 2023 - Chairman's Address - 24th Oct 2023, 8:13am
Replies
0
Views
70
annb0t
annb0t
Top Bottom